Literature DB >> 20844363

Outcomes of endoscopic submucosal dissection versus endoscopic mucosal resection in management of superficial squamous esophageal neoplasms outside Japan.

Anthony Yuen Bun Teoh1, Philip Wai Yan Chiu, Dennis Kwok Yu Ngo, Simon Kin Hung Wong, James Yun Wong Lau, Enders Kwok Wai Ng.   

Abstract

GOALS: This study aims to evaluate the outcomes of endoscopic submucosal dissection (ESD) versus endoscopic mucosal resection (EMR) in management of superficial squamous esophageal neoplasms.
BACKGROUND: Endoscopic resection is a potential alternative in treatment of superficial squamous esophageal neoplasms. However, there have been limited reports comparing the outcomes of ESD versus EMR in the treatment of these lesions outside Japan. STUDY: A retrospective analysis of all patients with high-grade superficial neoplasms (moderate to severe dysplasia and noninvasive carcinoma) or intramucosal carcinoma resected endoscopically between January 2002 and December 2007 was carried out. Clinical and pathologic outcomes were compared.
RESULTS: ESD was done in 22 lesions (18 patients) and cap-EMR in 13 lesions (10 patients). ESD allowed resection of larger lesions indicated by a significantly longer endoscopic length (P=0.015), larger specimen size (P<0.001), and more lesions extending for more than half the circumference of the esophagus (P=0.005) when compared with cap-EMR. ESD also achieved with a higher en bloc resection rate (P=0.052) and lower piecemeal resection rate (P=0.015). Procedure-related morbidities were not significantly different (P=1.0). There was no procedure-related mortality in the entire series.
CONCLUSIONS: ESD allows en bloc resection of larger mucosal lesions of the esophagus, earlier not possible by cap-EMR. This is achievable without significantly increasing the risks to the patient even in low-volume centers outside Japan. Whether ESD decreases the local recurrence and improves survival when compared with cap-EMR will require further long-term follow-up studies.

Entities:  

Mesh:

Year:  2010        PMID: 20844363     DOI: 10.1097/MCG.0b013e3181ce52fb

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  22 in total

1.  Endoscopic resection techniques and ablative therapies for Barrett's neoplasia.

Authors:  Jacobo Ortiz-Fernández-Sordo; Adolfo Parra-Blanco; Alejandro García-Varona; María Rodríguez-Peláez; Erika Madrigal-Hoyos; Irving Waxman; Luis Rodrigo
Journal:  World J Gastrointest Endosc       Date:  2011-09-16

2.  Endoscopic radiofrequency ablation for early esophageal squamous cell neoplasia: report of safety and effectiveness from a large prospective trial.

Authors:  Shun He; Jacques Bergman; Yueming Zhang; Bas Weusten; Liyan Xue; Xiumin Qin; Lizhou Dou; Yong Liu; David Fleischer; Ning Lu; Sanford M Dawsey; Gui-Qi Wang
Journal:  Endoscopy       Date:  2015-02-10       Impact factor: 10.093

3.  Endoscopic submucosal dissection combined with the placement of biodegradable stents for recurrent esophageal cancer after chemoradiotherapy.

Authors:  Yosuke Mochizuki; Yasuharu Saito; Toyohiko Tanaka; Norihisa Nitta; Hirokazu Yamada; Tomoyuki Tsujikawa; Kiyoshi Murata; Yoshihide Fujiyama; Akira Andoh
Journal:  J Gastrointest Cancer       Date:  2012-06

Review 4.  Efficacy and safety of endoscopic submucosal dissection for superficial squamous esophageal neoplasia: a meta-analysis.

Authors:  Joon Sung Kim; Byung-Wook Kim; In-Soo Shin
Journal:  Dig Dis Sci       Date:  2014-03-12       Impact factor: 3.199

Review 5.  Endoscopic submucosal dissection vs endoscopic mucosal resection for superficial esophageal cancer.

Authors:  Hui-Min Guo; Xiao-Qi Zhang; Min Chen; Shu-Ling Huang; Xiao-Ping Zou
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 6.  Barrett's esophagus in 2016: From pathophysiology to treatment.

Authors:  Irene Martinucci; Nicola de Bortoli; Salvatore Russo; Lorenzo Bertani; Manuele Furnari; Anna Mokrowiecka; Ewa Malecka-Panas; Vincenzo Savarino; Edoardo Savarino; Santino Marchi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

7.  The safety and efficacy of endoscopic submucosal dissection for treating early oesophageal carcinoma: a meta-analysis.

Authors:  H Y Wang; X Zeng; S Y Bai; K Pu; Y Zheng; R Ji; Q H Guo; Q L Guan; Y P Wang; Y N Zhou
Journal:  Ann R Coll Surg Engl       Date:  2020-08-21       Impact factor: 1.891

8.  Combination of endoscopic submucosal dissection and chemoradiation therapy for superficial esophageal squamous cell carcinoma with submucosal invasion.

Authors:  Yosuke Mochizuki; Yasuharu Saito; Tomoyuki Tsujikawa; Yoshihide Fujiyama; Akira Andoh
Journal:  Exp Ther Med       Date:  2011-07-14       Impact factor: 2.447

Review 9.  High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of endoscopic eradication therapy.

Authors:  Cadman L Leggett; Ganapathy A Prasad
Journal:  Curr Opin Gastroenterol       Date:  2012-07       Impact factor: 3.287

Review 10.  Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.

Authors:  George Sgourakis; Ines Gockel; Hauke Lang
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.